Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03920670 · ClinicalTrials.gov registry record · NA
Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT03920670: Completed NA study, sponsored by Mayo Clinic.
NCT03920670 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03920670, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The aim of this investigation is to compare the performance of two quantitative monitors utilized on post-anesthesia recovering patients. The ToFscan (Draeger Medical Inc., Telford, PA) represents one of the few standalone acceleromyography (AMG)-based quantitative monitors available for routine clinical use in the United States. The TetraGraph (Senzime AB, Uppsala, Sweden) is a standalone electromyography (EMG)-based quantitative monitor that recently received Conformité Européene (CE) approval. While both of these quantitative monitors can be utilized to guide intraoperative NMBA re-dosing and confirm recovery, they provide their objective data via drastically different techniques.
Interventions
- DEVICE TetraGraph (TG)
- DEVICE ToFscan (TS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03920670
The ClinicalTrials.gov registry entry for NCT03920670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TetraGraph (TG) is the first listed.
NCT03920670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03920670 about?
NCT03920670 is a clinical study titled "Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit". The aim of this investigation is to compare the performance of two quantitative monitors utilized on post-anesthesia recovering patients. The ToFscan (Draeger Medical Inc., Telford, PA) represents one of the few standalone acceleromyography (AMG)-based quantitative monitors available for routine cli...
What is the current status of trial NCT03920670?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2019-02-28. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT03920670?
The interventions under investigation include: TetraGraph (TG) (DEVICE), ToFscan (TS) (DEVICE).
Who is sponsoring clinical trial NCT03920670?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.